I am deeply interested in the subject of glycemia/HbA~1c~ relationships, underlying mechanisms, and impact on the assessment of glycemic control and diabetes prevalence. In the article by Soranzo et al. ([@B1]) published in *Diabetes*, the abstract indicates that adjusted HbA~1c~ would imply the reclassification of about 2% of the subjects in a general Caucasian population.

The table provided in Fig. 3 of that article is displayed below ([Table 1](#T1){ref-type="table"}) with the blank spaces filled with the corresponding figures and my reading of it.

Undiagnosed diabetes according to fasting plasma glucose 593/10,110 = 5.87%.Undiagnosed diabetes according to measured HbA~1c~ ≥6.5% = (234 + 112)/10,110 = 346/10,110 = 3.42%.Undiagnosed diabetes according to 7 single nucleotide polymorphism (SNP)-adjusted HbA~1c~ ≥6.5% = (222 + 96)/10,110 = 318/10,110 = 3.15%.

###### 

Reclassification of diabetes diagnoses performed using HbA~1c~ when genetic information is taken into account

                                              7 SNP-adjusted         
  ------------------------------------------- ---------------- ----- --------
  Undiagnosed diabetes                                               
   \<6.5%[\*](#tblfn1){ref-type="table-fn"}   358              1     359
   \>6.5%[\*](#tblfn1){ref-type="table-fn"}   13               221   234
   Subtotal                                   371              222   593
  Nondiabetes                                                        
   \<6.5%[\*](#tblfn1){ref-type="table-fn"}   9,404            1     9,405
   \>6.5%[\*](#tblfn1){ref-type="table-fn"}   17               95    112
   Subtotal                                   9,421            96    9,517
  Total                                       9,792            318   10,110

Data are *n*.

HbA~1c~.

At the population level, should diabetes diagnosis be performed using HbA~1c~, adjustment for 7 single nucleotide polymorphisms, would imply a net reclassification of 28 out of 10,110 subjects, an absolute difference in new diagnosis of −0.27% (3.15--3.42%) and a relative reduction of −7.9% (−0.27/3.42) × 100.
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